Proteomic analysis of highly prevalent amyloid a amyloidosis endemic to endangered Island foxes

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Gaffney, Patricia M ^a,b   Imai, Denise M ^b   Clifford, Deana L ^c,d   Ghassemian, Majid ^b   Sasik, Roman ^a   Chang, Aaron N ^a   O'Brien, Timothy D ^a   Coppinger, Judith ^a,f   Trejo, Margarita ^e   Masliah, Eliezer ^e   Munson, Linda ^b   Sigurdson, Christina ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Wildlife Investigations Laboratory   (United States)

^d CALIFORNIA DEPARTMENT OF FISH AND GAME   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FIBRINOGEN; SERUM AMYLOID A;

ADULT; AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; BINDING SITE; BLOOD VESSEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENDANGERED SPECIES; FEMALE; FOX; GENETIC VARIABILITY; IMMUNOHISTOCHEMISTRY; JUVENILE ANIMAL; KIDNEY; MALE; MASS SPECTROMETRY; MOUTH CAVITY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEOMICS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPLEEN; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; UROCYON LITTORALIS; UROCYON LITTORALIS CATALINAE; UROCYON LITTORALIS LITTORALIS; UROCYON LITTORALIS SANTACRUZAE; UROCYON LITTORALIS SANTAROSEA; YOUNG ADULT; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; ISLAND (GEOLOGICAL); METABOLISM; MOLECULAR GENETICS; MOUTH; PATHOLOGY; PREVALENCE; REPRODUCTIVE ISOLATION; ULTRASTRUCTURE; UNITED STATES; VETERINARY;

CANIDAE;

AMINO ACID SEQUENCE; AMYLOIDOSIS; ANIMALS; BLOOD VESSELS; CALIFORNIA; ENDANGERED SPECIES; FEMALE; FOXES; ISLANDS; KIDNEY; MALE; MOLECULAR SEQUENCE DATA; MOUTH; PREVALENCE; PROTEOMICS; REPRODUCTIVE ISOLATION; SERUM AMYLOID A PROTEIN; SPLEEN;

EID: 84956608536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113765     Document Type: Article

References (73)

1. Sipe JD, Ignaczak TF, Pollock PS, Glenner GG. (1976) Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay. J Immunol. 116: 1151-1156.
2. Benditt EP, Hoffman JS, Eriksen N, Parmelee DC, Walsh KA. (1982) SAA, an apoprotein of HDL: its structure and function. Ann N Y Acad Sci. 389: 183-189.
3. Lowell CA, Potter DA, Stearman RS, Morrow JF. (1986) Structure of the murine serum amyloid A gene family. Gene conversion. J Biol Chem. 261: 8442-8452.
4. Westermark GT, Sletten K, Grubb A, Westermark P. (1990) AA-amyloidosis. Tissue componentspecific association of various protein AA subspecies and evidence of a fourth SAA gene product. Am J Pathol. 137: 377-383.
5. Hagihara K, Nishikawa T, Sugamata Y, Song J, Isobe T, et al. (2005) Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells. 10: 1051-1063.
6. Simons JP, Al-Shawi R, Ellmerich S, Speck I, Aslam S, et al. (2013) Pathogenetic mechanisms of amyloid A amyloidosis. Proc Natl Acad Sci U S A. 110: 16115-16120.
7. McAdam KP, Sipe JD. (1976) Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med. 144: 1121-1127.
8. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 358: 24-29.
9. Uhlar CM, Whitehead AS. (1999) Serum amyloid A, the major vertebrate acute-phase reactant. European Journal of Biochemistry. 265: 501-523.
10. Lu J, Yu Y, Zhu I, Cheng Y, Sun PD. (2014) Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proc Natl Acad Sci U S A. 111: 5189-5194.
11. Patel H, Bramall J, Waters H, De Beer MC, Woo P. (1996) Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J. 318 (Pt 3): 1041-1049.
12. Elimova E, Kisilevsky R, Ancsin JB. (2009) Heparan sulfate promotes the aggregation of HDLassociated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch. FASEB Journal. 23: 3436-3448.
13. Elimova E, Kisilevsky R, Szarek WA, Ancsin JB. (2004) Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. FASEB Journal. 18: 1749-1751.
14. Westermark GT, Engstrom U, Westermark P. (1992) The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Commun. 182: 27-33.
15. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. (2004) Prediction of sequencedependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol. 22: 1302-1306.
16. Thompson MJ, Sievers SA, Karanicolas J, Ivanova MI, Baker D, et al. (2006) The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci U S A. 103: 4074-4078.
17. Husebekk A, Skogen B, Husby G, Marhaug G. (1985) Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol. 21: 283-287.
18. Rocken C, Menard R, Buhling F, Vockler S, Raynes J, et al. (2005) Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation. Ann Rheum Dis. 64: 808-815.
19. Liepnieks JJ, Kluve-Beckerman B, Benson MD. (1995) Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. Biochim Biophys Acta. 1270: 81-86.
20. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, et al. (2003) The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum. 48: 1149-1155.
21. Moriguchi M, Kaneko H, Terai C, Koseki Y, Kajiyama H, et al. (2005) Relative transcriptional activities of SAA1 promoters polymorphic at position 213(T/C): potential association between increased transcription and amyloidosis. Amyloid. 12: 26-32.
22. Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, et al. (1999) Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Human Genetics. 105: 360-366.
23. Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB. (1998) SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid. 5: 262-265.
24. Papendick RE, Munson L, O'Brien TD, Johnson KH. (1997) Systemic AA amyloidosis in captive cheetahs (Acinonyx jubatus). Vet Path. 34: 549-556.
25. Zhang B, Une Y, Ge F, Fu X, Qian J, et al. (2008) Characterization of the cheetah serum amyloid A1 gene: Critical role and functional polymorphism of a cis-acting element. J Heredity. 99: 355-363.
26. Gilbert DA, Lehman N, O'Brien SJ, Wayne RK . (1990) Genetic fingerprinting reflects population differentiation in the California Channel Island fox. Nature. 344: 764-767.
27. Theis JD, Dasari S, Vrana JA, Kurtin PJ, Dogan A. (2013) Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis. J Mass Spec. 48: 1067-1077.
28. Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR, 3rd, et al. (2009) Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 114: 4957-4959.
29. Williams S. (2004) Endangered and Threatened Wildlife and Plants; Listing the San Miquel Island Fox, Santa Rosa Island Fox, Santa Cruz Island Fox, and Santa Catalina Island Fox as Endangered. Department of the Interior Fish and Wildlife Service, Federal Register: Rules and Regulations: Vol 69, 50 CFR Part 17, pp. 10335-10353.
30. (2014) State and federally listed endangered and threatened animals of California. California Department of Fish and Wildlife, The Natural Resources Agency, California Natural Diveristy Database:Mammals. pp. 12.
31. Westermark P, Johnson KH, Sletten K, Hayden DW. (1985) AA-amyloidosis in dogs: partial amino acid sequence of protein AA and immunohistochemical cross-reactivity with human and cow AA-amyloid. Comp Biochem Physiol B. 82: 211-215.
32. Johnson KH, Sletten K, Hayden DW, O'Brien TD, Rossow KD, et al. (1995) AA amyloidosis in Chinese Shar-pei dogs: Immunohistochemical and amino acid sequence analyses. Amyloid. 2: 92-99.
33. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, et al. (2007) The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol & Cell Proteom. 6: 1638-1655.
34. Paoletti AC, Parmely TJ, Tomomori-Sato C, Sato S, Zhu D, et al. (2006) Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors. Proc Natl Acad Sci U S A. 103: 18928-18933.
35. Benjamini Y, Hochberg Y. (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Royal Stat Soc Series B. 57: 289-300.
36. Tusher VG, Tibshirani R, Chu G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 98: 5116-5121.
37. Maurer-Stroh S, Debulpaep M, Kuemmerer N, Lopez de la Paz M, Martins IC, et al. (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Methods. 7: 237-242.
38. Tartaglia GG, Pawar AP, Campioni S, Dobson CM, Chiti F, et al. (2008) Prediction of aggregationprone regions in structured proteins. J Molec Bio. 380: 425-436.
39. Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, et al. (1996) Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol. 35: 44-49.
40. Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, et al. (1994) Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol. 21: 33-36.
41. Koivuniemi R, Paimela L, Suomalainen R, Tornroth T, Leirisalo-Repo M. (2008) Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid. 15: 262-268.
42. Cohen AS, Calkins E. (1959) Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature. 183: 1202-1203.
43. Ancsin JB, Kisilevsky R. (1999) The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis. J. Biol Chem. 274: 7172-7181.
44. Sethi S, Vrana JA, Theis JD, Leung N, Sethi A, et al. (2012) Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int. 82: 226-234.
45. Mereuta OM, Theis JD, Vrana JA, Law ME, Grogg KL, et al. (2014) Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States. Blood. 123: 1479-1482.
46. Zhuo L, Kimata K. (2008) Structure and function of inter-alpha-trypsin inhibitor heavy chains. Connect Tissue Res. 49: 311-320.
47. Li L, Pesavento PA, Woods L, Clifford DL, Luff J, et al. (2011) Novel amdovirus in gray foxes. Emerg Infect Dis. 17: 1876-1878.
48. Kelly TR, Sleeman JM. (2003) Morbidity and mortality of red foxes (Vulpes vulpes) and gray foxes (Urocyon cinereoargenteus) admitted to the Wildlife Center of Virginia, 1993-2001. J Wildl Dis. 39: 467-469.
49. Lindsay DS, Weston JL, Little SE. (2001) Prevalence of antibodies to Neospora caninum and Toxoplasma gondii in gray foxes (Urocyon cinereoargenteus) from South Carolina. Vet Parasitol. 97: 159-164.
50. Davidson WR, Nettles VF, Hayes LE, Howerth EW, Couvillion CE. (1992) Diseases diagnosed in gray foxes (Urocyon cinereoargenteus) from the southeastern United States. J Wildl Dis. 28: 28-33.
51. Amundson TE, Yuill TM. (1981) Prevalence of selected pathogenic microbial agents in the red fox (Vulpes fulva) and gray fox (Urocyon cinereoargenteus) of southwestern Wisconsin. J Wildl Dis. 17: 17-22.
52. Miller MW, Williams ES. (2003) Prion disease: horizontal prion transmission in mule deer. Nature. 425: 35-36.
53. Lundmark K, Westermark GT, Nystrom S, Murphy CL, Solomon A, et al. (2002) Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci U S A. 99: 6979-6984.
54. Murakami T, Muhammad N, Inoshima Y, Yanai T, Goryo M, et al. (2013) Experimental induction and oral transmission of avian AA amyloidosis in vaccinated white hens. Amyloid. 20: 80-85.
55. Zhang B, Une Y, Fu X, Yan J, Ge F, et al. (2008) Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc Natl Acad Sci U S A. 105: 7263-7268.
56. Caughey B, Baron GS. (2008) Are cheetahs on the run from prion-like amyloidosis? Proc Natl Acad Sci U S A. 105: 7113-7114.
57. Hawkins PN, Richardson S, MacSweeney JE, King AD, Vigushin DM, et al. (1993) Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression. Q J Med. 86: 365-374.
58. Hawkins PN, Lavender JP, Pepys MB. (1990) Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med. 323: 508-513.
59. DiBartola SP, Tarr MJ, Webb DM, Giger U. (1990) Familial renal amyloidosis in Chinese Shar Pei dogs. J Am Vet Med Assoc. 197: 483-487.
60. Niewold TA, van der Linde-Sipman JS, Murphy C, Tooten PC, Gruys E. (1999) Familial amyloidosis in cats:Siamese and Abyssinian AA proteins differ in primary sequence and pattern of deposition. Amyloid. 6: 205-209.
61. Linke RP, Geisel O, Mann K. (1991) Equine cutaneous amyloidosis derived from an immunoglobulin lambda-light chain. Immunohistochemical, immunochemical and chemical results. Biol Chem Hoppe Seyler. 372: 835-843.
62. Cangul IT, Wijnen M, Van Garderen E, van den Ingh TS. (2002) Clinico-pathological aspects of canine cutaneous and mucocutaneous plasmacytomas. J Vet Med A Physiol Pathol Clin Med. 49: 307-312.
63. Rowland PH, Valentine BA, Stebbins KE, Smith CA. (1991) Cutaneous plasmacytomas with amyloid in six dogs. Vet Pathol. 28: 125-130.
64. Gouvea AF, Ribeiro AC, Leon JE, Carlos R, de Almeida OP, et al. (2012) Head and neck amyloidosis:clinicopathological features and immunohistochemical analysis of 14 cases. J Oral Pathol Med. 41: 178-185.
65. Penner CR, Muller S. (2006) Head and neck amyloidosis: a clinicopathologic study of 15 cases. Oral Oncol. 42: 421-429.
66. Kisilevsky R, Fraser PE. (1997) A beta amyloidogenesis: unique, or variation on a systemic theme? Crit Rev Biochem Mol Biol. 32: 361-404.
67. Li JP, Galvis ML, Gong F, Zhang X, Zcharia E, et al. (2005) In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. Proc Natl Acad Sci U S A. 102: 6473-6477.
68. Noborn F, Ancsin JB, Ubhayasekera W, Kisilevsky R, Li JP. (2012) Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation. J Bio Chem. 287: 25669-25677.
69. Wisniewski T, Frangione B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 135: 235-238.
70. Soto C, Castano EM, Prelli F, Kumar RA, Baumann M. (1995) Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Lett. 371: 110-114.
71. Kindy MS, Rader DJ. (1998) Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice. Am J Pathol. 152: 1387-1395.
72. Hoshii Y, Kawano H, Cui D, Takeda T, Gondo T, et al. (1997) Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice. Am J Pathol. 151: 911-917.
73. Yu JT, Tan L, Hardy J. (2014) Apolipoprotein E in Alzheimer's Disease: An Update. Annu Rev Neurosci. 37: 79-100.